Sino Biopharmaceutical
Asia, Hong Kong Island, Hong Kong, Wan Chai'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Sino Biopharmaceutical is a pharmaceutical company that engages in research, development and pharmaceutical products for treating diseases.
Investor Profile
Sino Biopharmaceutical has backed more than 5 startups, with 2 new investments in the last 12 months alone. The firm has led 4 rounds, about 80% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series D, Series B, Series C rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Led 2 rounds in the past year.
Stage Focus
- Series D (40%)
- Series B (20%)
- Series C (20%)
- Post Ipo Equity (20%)
Country Focus
- China (60%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- United States (40%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Artificial Intelligence (Ai)
- Biopharma
- Oncology
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
